V(H) and V(L) gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection

Blood

Volumn 88, Issue 9, 1996, Pages 3562-3568

  Chapman, Caroline J ^a   Zhou, Jo X ^b   Gregory, Chris ^b   Rickinson, Alan B ^b   Stevenson, Freda K ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; RNA; IMMUNOGLOBULIN A; TUMOR ANTIGEN;

ADOLESCENT; AMINO ACID SEQUENCE; ARTICLE; BURKITT LYMPHOMA; CHILD; CONTROLLED STUDY; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN VARIABLE REGION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SOMATIC MUTATION; ANIMAL; FEMALE; GENETICS; IMMUNOGLOBULIN GENE; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; MUTATION; SEQUENCE ANALYSIS;

ADOLESCENT; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BURKITT LYMPHOMA; FEMALE; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; MICE; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS;

EID: 0029661825     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3562.bloodjournal8893562     Document Type: Article

References (49)

1. Magrath I: The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 55:133, 1990
2. Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R: Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72:667, 1988
3. Hamilton-Dutoit SJ, Raphael M, Ardouin J, Diebold J, Lisee I, Pederson C, Oskenhendler E, Marelle L, Pallesen G: In situ demonstration of Epstein-Barr virus small RNAs (EBER1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site. Blood 82:619, 1993
4. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RW, Croce CM: Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79:7824, 1982
5. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P: Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkit lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79:7837, 1982
6. Cesarman E, Dalla-Favera R, Bentley D, Groudine M: Mutations in the first exon are associated with altered transcription of c-myc in Burkitt's lymphoma. Science 238:1272, 1987
7. Rabbitts TH, Hamlyn PH, Baer R: Altered nucleotide sequences of a translocated c-myc gene in Burkitt's lymphoma. Nature 306:760, 1983
8. Bhatia K, Huppi K, Sangler G, Siwarski D, Iyer R, Magrath I: Point mutations in the c-myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat Genet 5:56, 1993
9. Guy K, Middleton PG, Bonsai NS, Ross JA, Stell CM: Recurrent mutation of immunoglobulin and c-myc genes and differentiated expression of cell surface antigens occur in varient cell lines derived from a Burkitt's lymphoma. Int J Cancer 45:109, 1990
10. Lenoir G, Philip T, Sohier R: Burkitt type lymphoma: EBV association and cytogenetic markers in cases from various geographical locations, in Magrath IT, O'Conor GT, Ramat B (eds): Pathogenesis of Leukaemias and Lymphomas: Environmental Influences. New York, NY, Raven, 1984, p 283
11. Gutterez M, Bhatia K, Barriga F, Diez B, Muriel FS, de Andreas ML, Epelman S, Risveno C, Magrath IT: Molecular epidemiology of Burkitt's lymphoma from South America: Differences in breakpoint location and Epstein-Barr virus association from tumours in other world regions. Blood 79:3261, 1992
12. Philip T, Lenoir GM, Bryan PA, Gerard-Marchant R, Souillet G, Phillippe N, Freycon F, Brunat-Metigny M: Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. Br J Cancer 45:670, 1982
13. Zeigler JL: Burkitt's Lymphoma. N Engl J Med 305:735, 1981
14. Magrath IT, Zeigler JL: Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia. Leuk Res 4:33, 1980
15. Gregory CD, Tursz T, Edwards CF, Tataud C, Talbot M, Caillou B, Rickinson AB, Lipinski M: Identification of a subset of normal B cells with a Burkitt's lymphoma-like phenotype. J Immunol 139:313, 1987
16. Wright DH: Gross distribution and haematology, in Burkitt DP, Wright DH. (eds): Burkitt's lymphoma. Edinburgh, UK, Living-stone, 1970, p 64
17. Silberstein LE, Jefferies LC, Goldman J, Friedman D, Moore JS, Nowell PC, Roelcke D, Pruzanski W, Roudier J, Silverman GJ: Variable region gene analysis of pathological human autoantibodies to the related i and I red blood cell antigens. Blood 78:2372, 1991
18. H restriction among human cold agglutinins. The VH4-21 gene is required to encode anti-I and anti-i specificities. J Immunol 149:2337, 1992
19. Stevenson FK, Spellerberg MB, Treasure J, Chapman CJ, Silberstein LE, Hamblin TJ, Jones DB: Differential usage of an Ig heavy chain variable region gene by human B-cell tumors. Blood 82:224, 1993
20. H4 immunoglobulin gene family by diffuse large cell lymphoma. Blood 86:3072, 1995
21. Schroeder HW Jr, Dighiero G: The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire. Immunol Today 15:288, 1994
22. Küppers R, Ganse A, Rajewsky K: B cells of chronic lymphocytic leukemia express V genes in unmutated form. Leuk Res 15:487, 1991
23. Berek C: The development of B cells and the B-cell repertoire in the microenvironment of the germinal centres. Immunol Rev 126:5, 1992
24. Liu Y-J, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM: Mechanism of antigen-driven selection in germinal centres. Nature 342:929, 1989
25. Bahler DH, Levy R: Clonal evolution of a follicular lymphoma: Evidence for antigen selection. Proc Natl Acad Sci USA 89:6770, 1991
26. Sahota S, Hamblin T, Oscier DG, Stevenson FK: Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. Leukemia 8:1285, 1994
27. H genes used by neoplastic B cells in endemic Burkitt's lymphoma show somatic hypermutation and intraclonal heterogeneity. Blood 85:2176, 1995
28. Jain R, Roncella S, Hashimoto S, Carbone A, Francia de Celle P, Foa R, Ferrarini M, Chiorazzi N: A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J Immunol 153:45, 1994
29. H-gene putative somatic mutation analysis. Blood 83:1067, 1994
30. H 4-21 Segments. Blood 83:2952, 1994
31. Rowe M, Rooney CM, Edwards CF, Lenoir GM, Rickinson AB: Epstein-Barr virus status and tumor cell phenotype in sporadic Burkitt's lymphoma. Int J Cancer 37:367, 1986
32. Benjamin D, Magrath IT, Maguire R, Janus C, Todd HD, Parson RG: Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's types. J Immunol 129:1336, 1982
33. Van Santen V, Cheung A, Kieef E: Epstein-Barr virus RNA. VII. Size and direction of transcription of virus-specific cytoplasmic RNAs in a transformed cell line. Proc Natl Acad Sci USA 78:1930, 1981
34. Cohen JMH, Revillard JP, Magaud JP, Lenoir G, Vuillaume M, Manel AM, Vincent C, Bryon PA: B-cell maturation stages of Burkilt's lymphoma cell lines according to EBV status and type of chromosome translocation. J Natl Cancer Inst 78:235, 1987
35. Finery S, Rowe M, Berry PJ, Ranson DL, Mott MG, Gregory CD, Rickinson AB: Burkitt-like lymphoma in an English child: Characterisation of tumour biopsy cells and of the derived tumour cell line. Br J Cancer 54:385, 1986
36. Moazzeni M, Mosayyebi G, Stevenson FK, Abbot S, Mageed RA, Shokri F: Biased utilization of immunoglobulin variable region heavy and light chain genes by the malignant CDS-negative B lymphocytes from patients with Burkitt's lymphoma. Int J Cancer 58:226, 1994
37. Campbell MJ, Zelenetz AD, Levy S, Levy R: Use of family specific leader region primers for PCR amplification of the human heavy-chain variable region gene repertoire. Mol Immunol 29:193, 1992
38. H4-21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching. Mol Immunol 32:347, 1995
39. H4-21 gene segment. J Immunol 151:1051, 1993
40. Pascual V, Victor K, Lelsz D, Spellerberg MB, Hamblin TJ, Thompson KM, Randen I, Natvig J, Capra JD, Stevenson FK: Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. J Immunol 146:4385, 1991
41. Williams SC, Winter G: Cloning and sequencing of human immunoglobulin Vλ gene segments. Eur J Immunol 23:1456, 1993
42. H genes are inherently susceptible to animo acid replacement. Immunol Today 15:367, 1994
43. Cogne M, Mounir S, Aucouturier P, Pred'homme JL, Nau F, Gugliemi P: Immunoglobulin light chain transcripts with altered V regions in Burkitt's lymphoma cell lines producing short μ chains. Eur J Immunol 20:1905, 1990
44. Burkitt D: A sarcoma involving the jaws in African children. Br J Surg 46:218, 1958
45. Haluska FG, Finser S, Tsujimoto Y, Croce C: The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. Nature 324:158, 1986
46. Gray D: Immunological memory. Ann Rev Immunol 11:49, 1993
47. Klein U, Klein G, Ehlin-Henriksson, Rajewsky K, Küppers R: Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes. Mol Med 1:495, 1995
48. Zhu D, Hawkins RE, Hamblin TJ, Stevenson FK: Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes. Br J Haematol 86:505, 1994
49. H genes with a moderate number of antigen-selected somatic mutations. Am J Pathol 147:1398, 1995